By Michael Dabaie

Mylan N.V. (MYL) and Pfizer Inc. (PFE) said the name of the new company to be formed by the planned combination of Mylan and Pfizer's Upjohn will be Viatris.

Customers and patients will continue to be served by the Mylan and Upjohn brands for the near future. The new name will be effective upon closing of the combination, which is expected to occur in mid-2020, the companies said.

The companies said in July that they agreed to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, creating a new pharmaceutical company.

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

November 12, 2019 13:07 ET (18:07 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Pfizer.
Pfizer (NYSE:PFE)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Pfizer.